Danielle Baum

1.4k total citations
14 papers, 794 citations indexed

About

Danielle Baum is a scholar working on Dermatology, Immunology and Physiology. According to data from OpenAlex, Danielle Baum has authored 14 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Dermatology, 7 papers in Immunology and 3 papers in Physiology. Recurrent topics in Danielle Baum's work include Dermatology and Skin Diseases (3 papers), Diabetes and associated disorders (3 papers) and Immunotherapy and Immune Responses (3 papers). Danielle Baum is often cited by papers focused on Dermatology and Skin Diseases (3 papers), Diabetes and associated disorders (3 papers) and Immunotherapy and Immune Responses (3 papers). Danielle Baum collaborates with scholars based in United States, Switzerland and Italy. Danielle Baum's co-authors include Thomas L. Creer, Audrey Defusco, Daniel Huang, Giselle Singer, Mark Lebwohl, Denise L. Faustman, Emma Guttman‐Yassky, Ana B. Pavel, Heather Torrey and Lisa Tran and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Danielle Baum

12 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle Baum United States	10	403	289	168	144	97	14	794
Annette Haagerup Denmark	16	194 0.5×	112 0.4×	149 0.9×	298 2.1×	180 1.9×	35	771
V. Sigurdsson Netherlands	21	333 0.8×	604 2.1×	123 0.7×	47 0.3×	153 1.6×	55	1.2k
D.-D. Lee Taiwan	8	123 0.3×	251 0.9×	122 0.7×	112 0.8×	44 0.5×	8	597
M Kristensen Denmark	10	257 0.6×	144 0.5×	70 0.4×	64 0.4×	80 0.8×	18	639
Greg Kricorian United States	19	946 2.3×	767 2.7×	49 0.3×	192 1.3×	91 0.9×	34	1.4k
Başak Yalçın Türkiye	19	140 0.3×	447 1.5×	58 0.3×	73 0.5×	114 1.2×	88	1.1k
Gary Tran United States	10	117 0.3×	260 0.9×	167 1.0×	133 0.9×	106 1.1×	17	553
N. Doss Tunisia	14	157 0.4×	335 1.2×	81 0.5×	55 0.4×	30 0.3×	55	585
Marni Wiseman Canada	20	127 0.3×	612 2.1×	82 0.5×	49 0.3×	76 0.8×	56	1.0k
Marlies de Graaf Netherlands	17	77 0.2×	356 1.2×	252 1.5×	124 0.9×	98 1.0×	63	867

Countries citing papers authored by Danielle Baum

Since Specialization

Citations

This map shows the geographic impact of Danielle Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Baum more than expected).

Fields of papers citing papers by Danielle Baum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Baum. The network helps show where Danielle Baum may publish in the future.

Co-authorship network of co-authors of Danielle Baum

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Baum. A scholar is included among the top collaborators of Danielle Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Baum. Danielle Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kim, Hee J., Ester Del Duca, Ana B. Pavel, et al.. (2022). Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV–VI. Archives of Dermatological Research. 315(2). 215–221. 10 indexed citations

Sui, Lina, Yurong Xin, Leena Haataja, et al.. (2021). Reduced replication fork speed promotes pancreatic endocrine differentiation and controls graft size. JCI Insight. 6(5). 25 indexed citations

Ungar, Benjamin, Jacob W. Glickman, Celina Dubin, et al.. (2021). COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab. The Journal of Allergy and Clinical Immunology In Practice. 10(1). 134–142. 29 indexed citations

Skowronski, Alicja A., Danielle Baum, Sebastian Thams, et al.. (2019). Transgenic substitution with Greater Amberjack Seriola dumerili fish insulin 2 in NOD mice reduces beta cell immunogenicity. Scientific Reports. 9(1). 4965–4965.

Hashim, Peter W., Margot Chima, Hee J. Kim, et al.. (2019). Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial. Journal of the American Academy of Dermatology. 82(2). 360–365. 35 indexed citations

Guttman‐Yassky, Emma, Patrick M. Brunner, Avidan U. Neumann, et al.. (2018). Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial. Journal of the American Academy of Dermatology. 78(5). 872–881.e6. 256 indexed citations

Mikhaylov, Daniela, Ana B. Pavel, Christopher J. Yao, et al.. (2018). A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata. Archives of Dermatological Research. 311(1). 29–36. 46 indexed citations

Kühtreiber, Willem M., Lisa Tran, Michael P. Dybala, et al.. (2018). Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations. npj Vaccines. 3(1). 23–23. 130 indexed citations

Torrey, Heather, Michael S. Khodadoust, Lisa Tran, et al.. (2018). Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome. Leukemia. 33(5). 1206–1218. 49 indexed citations

10.

Torrey, Heather, Audrey Defusco, Danielle Baum, et al.. (2018). Abstract B18: Novel treatment of cutaneous T cell lymphoma: Targeting TNFR2, an oncogene and marker of potent Tregs, with anti-TNFR2 antibodies. Cancer Immunology Research. 6(9_Supplement). B18–B18. 1 indexed citations

11.

Faustman, Denise L., Heather Torrey, John Butterworth, et al.. (2017). Targeting the TNFR2 oncogene on tumor cells and tregs of the tumor microenvironment via dominant TNFR2 antagonism.. Journal of Clinical Oncology. 35(7_suppl). 106–106.

12.

Torrey, Heather, John Butterworth, Toshiyuki Mera, et al.. (2017). Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated T _regs. Science Signaling. 10(462). 147 indexed citations

13.

Burger, Douglas C., et al.. (2015). TNFR1 and TNFR2 Expression and Induction on Human Treg Cells from Type 1 Diabetic Subjects. SHILAP Revista de lepidopterología. 4(1). 34–47. 4 indexed citations

14.

Baum, Danielle & Thomas L. Creer. (1986). Medication Compliance in Children with Asthma. Journal of Asthma. 23(2). 49–59. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact